Molecular targets of omega 3 and conjugated linoleic fatty acids - "Micromanaging" cellular response

Frontiers in Physiology

Volumn 3 FEB, Issue , 2012, Pages 1-11

  Visioli, Francesco ^a   Giordano, Elena ^a   Nicod, Nathalie Marie ^a   Dávalos, Alberto ^a  

^a IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Atherosclerosis; Cardiovascular system; Essential fatty acids; Hdl; Microrna; Molecular targets

Indexed keywords

EID: 84863528650     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00042     Document Type: Article

References (106)

1. Andreo, U., Elkind, J., Blachford, C., Cederbaum, A. I., and Fisher, E. A. (2011). Role of superoxide rad-ical anion in the mechanism of apoB100 degradation induced by DHA in hepatic cells. FASEB J. 25, 3554-3560.
2. Banni, S. (2002). Conjugated linoleic acid metabolism. Curr. Opin. Lipi-dol. 13, 261-266.
3. Bartel, D. P. (2009). MicroRNAs: tar-get recognition and regulatory func-tions. Cell 136, 215-233.
4. Belury, M. A. (2002). Dietary conju-gated linoleic acid in health: phys-iological effects and mechanisms of action. Annu.Rev.Nutr.22,505-531.
5. Benjamin, S., and Spener, F. (2009). Conjugated linoleic acids as func-tional food: an insight into their health benefits. Nutr. Metab. (Lond.) 6, 36.
6. Bhattacharya, A., Banu, J., Rahman, M., Causey, J., and Fernandes, G. (2006). Biological effects of con-jugated linoleic acids in health and disease. J. Nutr. Biochem. 17, 789-810.
7. Billman, G. E., Kang, J. X., and Leaf, A. (1999). Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 99, 2452-2457.
8. Birney, E., Stamatoyannopoulos, J. A., Dutta, A., Guigo, R., Gingeras, T. R., Margulies, E. H., Weng, Z., Sny-der, M., Dermitzakis, E. T., Thur-man, R. E., Kuehn, M. S., Tay-lor, C. M., Neph, S., Koch, C. M., Asthana, S., Malhotra, A., Adzhubei, I., Greenbaum, J. A., Andrews, R. M., Flicek, P., Boyle, P. J., Cao, H., Carter, N. P., Clelland, G. K., Davis, S., Day, N., Dhami, P., Dillon, S. C., Dorschner, M. O., Fiegler, H., Giresi, P. G., Goldy, J., Hawrylycz, M., Hay-dock, A., Humbert, R., James, K. D., Johnson, B. E., Johnson, E. M., Frum, T. T., Rosenzweig, E. R., Kar-nani, N., Lee, K., Lefebvre, G. C., Navas, P. A., Neri, F., Parker, S. C., Sabo, P. J., Sandstrom, R., Shafer, A., Vetrie, D., Weaver, M., Wilcox, S., Yu, M., Collins, F. S., Dekker, J., Lieb, J. D., Tullius, T. D., Crawford, G. E., Sunyaev, S., Noble, W. S., Dun-ham, I., Denoeud, F., Reymond, A., Kapranov, P., Rozowsky, J., Zheng, D., Castelo, R., Frankish, A., Harrow, J., Ghosh, S., Sandelin, A., Hofacker, I. L., Baertsch, R., Keefe, D., Dike, S., Cheng, J., Hirsch, H. A., Sekinger, E. A., Lagarde, J., Abril, J. F., Shahab, A., Flamm, C., Fried, C., Hackermüller, J., Hertel, J., Lindemeyer, M., Missal, K., Tanzer, A., Washietl, S., Kor-bel, J., Emanuelsson, O., Pedersen, J. S., Holroyd, N., Taylor, R., Swar-breck, D., Matthews, N., Dickson, M. C., Thomas, D. J., Weirauch, M. T., Gilbert, J., Drenkow, J., Bell, I., Zhao, X., Srinivasan, K. G., Sung, W. K., Ooi, H. S., Chiu, K. P., Foissac, S., Alioto, T., Brent, M., Pachter, L., Tress, M. L., Valencia, A., Choo, S. W., Choo, C. Y., Ucla, C., Manzano, C., Wyss, C., Cheung, E., Clark, T. G., Brown, J. B., Ganesh, M., Patel, S., Tammana, H., Chrast, J., Hen-richsen, C. N., Kai, C., Kawai, J., Nagalakshmi, U., Wu, J., Lian, Z., Lian, J., Newburger, P., Zhang, X., Bickel, P., Mattick, J. S., Carninci, P., Hayashizaki, Y., Weissman, S., Hub-bard, T., Myers, R. M., Rogers, J., Stadler, P. F., Lowe, T. M., Wei, C. L., Ruan, Y., Struhl, K., Gerstein, M., Antonarakis, S. E., Fu, Y., Green, E. D., Karaöz, U., Siepel, A., Taylor, J., Liefer, L. A., Wetterstrand, K. A., Good, P. J., Feingold, E. A., Guyer, M. S., Cooper, G. M., Asimenos, G., Dewey, C. N., Hou, M., Nikolaev, S., Montoya-Burgos, J. I., Löytynoja, A., Whelan, S., Pardi, F., Massing-ham, T., Huang, H., Zhang, N. R., Holmes, I., Mullikin, J. C., Ureta-Vidal, A., Paten, B., Seringhaus, M., Church, D., Rosenbloom, K., Kent, W. J., Stone, E. A., Batzoglou, S., Goldman, N., Hardison, R. C., Haus-sler, D., Miller, W., Sidow, A., Trin-klein, N. D., Zhang, Z. D., Barrera, L., Stuart, R., King, D. C., Ameur, A., Enroth, S., Bieda, M. C., Kim, J., Bhinge, A. A., Jiang, N., Liu, J., Yao, F., Vega, V. B., Lee, C. W., Ng, P., Sha-hab, A., Yang, A., Moqtaderi, Z., Zhu, Z., Xu, X., Squazzo, S., Oberley, M. J., Inman, D., Singer, M. A., Richmond, T. A., Munn, K. J., Rada-Iglesias, A., Wallerman, O., Komorowski, J., Fowler, J. C., Couttet, P., Bruce, A. W., Dovey, O. M., Ellis, P. D., Lang-ford, C. F., Nix, D. A., Euskirchen, G., Hartman, S., Urban, A. E., Kraus, P., Van Calcar, S., Heintzman, N., Kim, T. H., Wang, K., Qu, C., Hon, G., Luna, R., Glass, C. K., Rosenfeld, M. G., Aldred, S. F., Cooper, S. J., Halees, A., Lin, J. M., Shulha, H. P., Zhang, X., Xu, M., Haidar, J. N., Yu, Y., Ruan, Y., Iyer, V. R., Green, R. D., Wadelius, C., Farnham, P. J., Ren, B., Harte, R. A., Hinrichs, A. S., Trumbower, H., Clawson, H., Hillman-Jackson, J., Zweig, A. S., Smith, K., Thakka-pallayil, A., Barber, G., Kuhn, R. M., Karolchik, D., Armengol, L., Bird, C. P.,de Bakker, P. I., Kern, A. D., Lopez-Bigas, N., Martin, J. D., Stranger, B. E., Woodroffe, A., Davydov, E., Dimas, A., Eyras, E., Hallgrímsdóttir, I. B., Huppert, J., Zody, M. C., Abeca-sis, G. R., Estivill, X., Bouffard, G. G., Guan, X., Hansen, N. F., Idol, J. R., Maduro, V. V., Maskeri, B., McDow-ell, J. C., Park, M., Thomas, P. J., Young, A. C., Blakesley, R.W., Muzny, D. M., Sodergren, E., Wheeler, D. A., Worley, K. C., Jiang, H., Wein-stock, G. M., Gibbs, R. A., Graves, T., Fulton, R., Mardis, E. R., Wilson, R. K., Clamp, M., Cuff, J., Gnerre, S., Jaffe, D. B., Chang, J. L., Lindblad-Toh, K., Lander, E. S., Koriabine, M., Nefedov, M., Osoegawa, K., Yoshi-naga, Y., Zhu, B., and de Jong, P. J. (2007). Identification and analy-sis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816.
9. Black, I. L., Roche, H. M., and Gibney, M. J. (2002). Chronic but not acute treatment with conjugated linoleic acid (CLA) isomers (trans-10, cis-12 CLA and cis-9, trans-11 CLA) affects lipid metabolism in Caco-2 cells. J. Nutr. 132, 2167-2173.
10. Boekholdt, S. M., Keller, T. T., Ware-ham, N. J., Luben, R., Bingham, S. A., Day, N. E., Sandhu, M. S., Jukema, J. W., and Kastelein, J. J., Hack, C. E., and Khaw, K. T. (2005). SerumlevelsoftypeIIsecretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Pop-ulation Study. Arterioscler. Thromb. Vasc. Biol. 25, 839-846.
11. Bouchard, L., Tchernof, A., Deshaies, Y., Marceau, S., Lescelleur, O., Biron, S., and Vohl, M. C. (2007). ZFP36: a promising candidate gene for obesity-related metabolic com-plications identified by converg-ing genomics. Obes. Surg. 17, 372-382.
12. Brouwer, I. A., Raitt, M. H., Dullemei-jer, C., Kraemer, D. F., Zock, P. L., Morris, C., Katan, M. B., Connor, W. E., Camm, J. A., Schouten, E. G., and McAnulty, J. (2009). Effect of fish oil on ventricular tachyarrhyth-mia in three studies in patients with implantable cardioverter defibrillators. Eur. Heart J. 30, 820-826.
13. Brown, J. M., Boysen, M. S., Chung, S., Fabiyi, O., Morrison, R. F., Mandrup, S., and McIntosh, M. K. (2004). Conjugated linoleic acid induces human adipocyte delip-idation: autocrine/paracrine regu-lation of MEK/ERK signaling by adipocytokines. J. Biol. Chem. 279, 26735-26747.
14. Brown, J. M., Boysen, M. S., Jensen, S. S., Morrison, R. F., Storkson, J., Lea-Currie, R., Pariza, M., Mandrup, S., and McIntosh, M. K. (2003). Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. J. Lipid Res. 44, 1287-1300.
15. Burleigh, M. E., Babaev, V. R., Oates, J. A., Harris, R. C., Gautam, S., Rien-deau, D., Marnett, L. J., Morrow, J. D., and Fazio, S., and Linton, M. F. (2002). Cyclooxygenase-2 promotes early atherosclerotic lesion forma-tion in LDL receptor-deficient mice. Circulation 105, 1816-1823.
16. Caviglia, J. M., Gayet, C., Ota, T., Hernandez-Ono, A., Conlon, D. M., Jiang, H., Fisher, E. A., and Gins-berg, H. N. (2011). Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy. J. Lipid Res. 52, 1636-1651.
17. Cheloufi, S., Dos Santos, C. O., Chong, M. M., and Hannon, G. J. (2010). A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 465, 584-589.
18. Chen, M., Yang, Y. K., Loux, T. J., Georgeson, K. E., and Harmon, C. M. (2006). The role of hyper-glycemia in FAT/CD36 expression and function. Pediatr. Surg. Int. 22, 647-654.
19. Churruca, I., Fernandez-Quintela, A., and Portillo, M. P. (2009). Conjugated linoleic acid isomers: differences in metabolism and biological effects. Biofactors 35, 105-111.
20. Clement, L., Poirier, H., Niot, I., Bocher, V., Guerre-Millo, M., Krief, S., Staels, B., and Besnard, P. (2002). Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J. Lipid Res. 43, 1400-1409.
21. Danaei, G., Ding, E. L., Mozaffar-ian, D., Taylor, B., Rehm, J., Mur-ray, C, and Ezzati, M. (2009). The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 6, e1000058. doi:10.1371/jour-nal.pmed.1000058
22. Davidson, L. A., Wang, N., Shah, M. S., Lupton, J. R., Ivanov, I., and Chapkin, R. S. (2009). n-3 Polyunsaturated fatty acids modu-late carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 30, 2077-2084.
23. Degrace, P., Demizieux, L., Gresti, J., Chardigny, J. M., Sebedio, J. L., and Clouet, P. (2003). Association of liver steatosis with lipid over-secretion and hypotriglyceridaemia in C57BL/6j mice fed trans-10,cis-12-linoleic acid. FEBS Lett. 546, 335-339.
24. Ecker, J., Liebish, G., Patsch, W., and Schmitz, G. (2009). The conjugated linoleic acid isomer trans-9,trans-11 is a dietary occurring agonist of liver X receptor alpha. Biochem. Biophys. Res. Commun. 388, 660-666.
25. Esau, C., Kang, X., Peralta, E., Hanson, E., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., Dean, N. M., Freier, S. M., Bennett, C. F., Lollo, B., and Grif-fey, R. (2004). MicroRNA-143 reg-ulates adipocyte differentiation. J. Biol. Chem. 279, 52361-52365.
26. Farago, N., Feher, L. Z., Kitajka, K., Das, U. N., and Puskas, L. G. (2011). MicroRNA profile of polyunsatu-rated fatty acid treated glioma cells reveal apoptosis-specific expression changes. Lipids Health Dis. 10, 173.
27. Ferrucci, L., Cherubini, A., Bandinelli, S., Bartali, B., Corsi, A., Lau-retani, F., Martin, A., Andres-Lacueva, C., Senin, U., and Gural-nik, J. M. (2006). Relationship of plasma polyunsaturated fatty acids to circulating inflammatory mark-ers. J. Clin. Endocrinol. Metab. 91, 439-446.
28. Fredman, G., and Serhan, C. N. (2011). Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem. J. 437, 185-197.
29. Granlund, L., Pedersen, J. I., and Nebb, H. I. (2005). Impaired lipid accumu-lation by trans10, cis12 CLA during adipocyte differentiation is depen-dent on timing and length of treat-ment. Biochim. Biophys. Acta 1687, 11-22.
30. Guillot, N., Caillet, E., Laville, M., Calzada, C., Lagarde, M., and Veri-cel, E. (2009). Increasing intakes of the long-chain omega-3 docosa-hexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J. 23, 2909-2916.
31. Guzik, T. J., and Harrison, D. G. (2006).Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov. Today 11, 524-533.
32. Herrmann, J., Rubin, D., Hasler, R., Hel-wig, U., Pfeuffer, M., Auinger, A., Laue, C., Winkler, P., Schreiber, S., Bell, D., and Schrezenmeir, J. (2009). Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over study. Lipids Health Dis. 8, 35.
33. Higdon, J. V., Du, S. H., Lee, Y. S., Wu, T., and Wander, R. C. (2001). Sup-plementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate. J. Lipid Res. 42, 407-418.
34. Higdon, J. V., Liu, J., Du, S. H., Mor-row, J. D., Ames, B. N., and Wan-der, R. C. (2000). Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associ-ated with greater in vivo lipid perox-idation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F(2)-isoprostanes. Am. J. Clin. Nutr. 72, 714-722.
35. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z., Uysal, K. T., Maeda, K., Karin, M., and Hotamisligil, G. S. (2002).A central role for JNK in obe-sity and insulin resistance. Nature 420, 333-336.
36. Holzer, R. G., Park, E. J., Li, N., Tran, H., Chen, M., Choi, C., Solinas, G., and Karin, M. (2011). Satu-rated fatty acids induce c-Src cluster-ing within membrane subdomains, leading to JNK activation. Cell 147, 173-184.
37. Hussain, M. A., Schmitz, O., Mengel, A., Keller, A., Christiansen, J. S., Zapf, J., and Froesch, E. R. (1993). Insulin-like growth factor I stimu-lates lipid oxidation, reduces protein oxidation, and enhances insulin sen-sitivity in humans. J. Clin. Invest. 92, 2249-2256.
38. Jenkins, D. J., Josse, A. R., Dorian, P., Burr, M. L., LaBelle, T. R., Kendall, C. W., and Cunnane, S. C. (2008). Heterogeneity in randomized con-trolled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricu-lar arrhythmias. J. Am. Coll. Nutr. 27, 367-378.
39. Kang, J. X., and Weylandt, K. H. (2008). Modulation of inflam-matory cytokines by omega-3 fatty acids. Subcell. Biochem. 49, 133-143.
40. Kennedy, A., Chung, S., LaPoint, K., Fabiyi, O., and McIntosh, M. K. (2008). Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. J. Nutr. 138, 455-461.
41. Kennedy, A., Martinez, K., Schmidt, S., Mandrup, S., LaPoint, K., and McIntosh, M. (2010). Antiobesity mechanisms of action of conjugated linoleic acid. J. Nutr. Biochem. 21, 171-179.
42. Kim, E. J., Kang, I. J., Cho, H. J., Kim, W. K., Ha, Y. L., and Park, J. H. (2003). Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. J. Nutr. 133, 2675-2681.
43. Kosaka, N., Iguchi, H., and Ochiya, T. (2010). Circulating microRNA in body fluid: a new poten-tial biomarker for cancer diagno-sis and prognosis. Cancer Sci. 101, 2087-2092.
44. Krol, J., Loedige, I., and Filipowicz, W. (2010). The widespread regula-tion of microRNA biogenesis, func-tion and decay. Nat. Rev. Genet. 11, 597-610.
45. Lamaziere, A., Richard, D., Barbe, U., Kefi, K., Bausero, P., Wolf, C., and Visioli, F. (2011). Differential dis-tribution of DHA-phospholipids in rat brain after feeding: a lipidomic approach. Prostaglandins Leukot. Essent. Fatty Acids 84, 7-11.
46. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfef-fer, S., Rice, A., Kamphorst, A. O., Landthaler, M., Lin, C., Socci, N. D., Hermida, L., Fulci, V., Chiaretti, S., Foà, R., Schliwka, J., Fuchs, U., Novosel, A., Müller, R. U., Schermer, B., Bissels, U., Inman, J., Phan, Q., Chien, M., Weir, D. B., Choksi, R., De Vita, G., Frezzetti, D., Trompeter, H. I., Hornung, V., Teng, G., Hart-mann, G., Palkovits, M., Di Lauro, R., Wernet, P., Macino, G., Rogler, C. E., Nagle, J. W., Ju, J., Papavasil-iou, F. N., Benzing, T., Lichter, P., Tam, W., Brownstein, M. J., Bosio, A., Borkhardt, A., Russo, J. J., Sander, C., Zavolan, M., and Tuschl, T. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
47. Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lin-dow, M., Munk, M. E., Kauppinen, S., and Orum, H. (2010). Thera-peutic silencing of microRNA-122 in primates with chronic hepati-tis C virus infection. Science 327, 198-201.
48. LaRosa, P. C., Miner, J., Xia, Y., Zhou, Y., Kachman, S., and Fromm, M. E. (2006). Trans-10, cis-12 conjugated linoleic acid causes inflammation and delipidation of white adipose tissue in mice: a microarray and his-tological analysis. Physiol. Genomics 27, 282-294.
49. Leaf, A., Kang, J. X., and Xiao, Y. F. (2008). Fish oil fatty acids as cardio-vascular drugs. Curr. Vasc. Pharma-col. 6, 1-12.
50. Leaver, H. A., Bell, H. S., Rizzo, M. T., Ironside, J. W., Gregor, A., Wharton, S. B., and Whittle, I. R. (2002). Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot. Essent. Fatty Acids 66, 19-29.
51. Lee, R. C., Feinbaum, R. L., and Ambros, V. (1993). The C. elegans hete-rochronic gene lin-4 encodes small RNAs with antisense complementar-ity to lin-14. Cell 75, 843-854.
52. Leon, H., Shibata, M. C., Sivakumaran, S., Dorgan, M., Chatterley, T., and Tsuyuki, R. T. (2008). Effect of fish oil on arrhythmias and mor-tality: systematic review. BMJ 337, a2931.
53. Li, H., Zhang, Z., Zhou, X., Wang, Z., Wang, G.,and Han, Z. (2011). Effects of microRNA-143 in the differen-tiation and proliferation of bovine intramuscular preadipocytes. Mol. Biol. Rep. 38, 4273-4280.
54. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCom-bie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hib-shoosh, H., Wigler, M. H., and Par-sons, R. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947.
55. Liu, L. F., Purushotham, A., Wendel, A. A., and Belury, M. A. (2007). Com-bined effects of rosiglitazone and conjugated linoleic acid on adipos-ity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1671-G1682.
56. Mas, E., Woodman, R. J., Burke, V., Puddey, I. B., Beilin, L. J., Durand, T., and Mori, T. A. (2010). The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: results from two placebo-controlled interventions. Free Radic. Res. 44, 983-990.
57. Massaro, M., Habib, A., Lubrano, L., Del Turco, S., Lazzerini, G., Bourcier, T., Weksler, B. B., and De Cate-rina, R. (2006). The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induc-tion through both NADP(H) oxi-dase and PKC epsilon inhibition. Proc. Natl. Acad. Sci. U.S.A. 103, 15184-15189.
58. Mattick, J. S. (2011). The central role of RNA in human development and cognition. FEBS Lett. 585, 1600-1616.
59. Mauerer, R., Ebert, S., and Langmann, T. (2009). High glucose, unsatu-rated and saturated fatty acids dif-ferentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages. Exp. Mol. Med. 41, 126-132.
60. Mayr, B., and Montminy, M. (2001). Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599-609.
61. Mercer, T. R., Gerhardt, D. J., Dinger, M. E., Crawford, J., Trapnell, C., Jeddeloh, J. A., Mattick, J. S., and Rinn, J. L. (2011). Targeted RNA sequencing reveals the deep com-plexity of the human transcriptome. Nat. Biotechnol. 30, 99-104.
62. Moloney, F., Toomey, S., Noone, E., Nugent, A., Allan, B., Loscher, C. E., and Roche, H. M. (2007). Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Dia-betes 56, 574-582.
63. Mori, T. A. (2004). Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation. Redox Rep. 9, 193-197.
64. Mori, T. A., and Beilin, L. J. (2004). Omega-3 fatty acids and inflam-mation. Curr. Atheroscler. Rep. 6, 461-467.
65. Murthy, S., Born, E., Mathur, S. N., and Field, F. J. (2004). Liver-X-receptor-mediated increase in ATP-binding cassette transporter A1 expression is attenuated by fatty acids in CaCo-2 cells: effect on cholesterol efflux to high-density lipoprotein. Biochem. J. 377, 545-552.
66. Ochoa, J. J., Farquharson, A. J., Grant, I., Moffat, L. E., Heys, S. D., and Wahle, K. W. (2004). Conjugated linoleic acids (CLAs) decrease prostate can-cer cell proliferation: different mole-cular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Car-cinogenesis 25, 1185-1191.
67. Oh, D. Y., Talukdar, S., Bae, E. J., Ima-mura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., and Olefsky, J. M. (2010). GPR120 is an omega-3 fatty acid receptor medi-ating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698.
68. Pan, M., Cederbaum, A. I., Zhang, Y. L., Ginsberg, H. N., Williams, K. J., and Fisher, E. A. (2004). Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 113, 1277-1287.
69. Pariza, M. W., Park, Y., and Cook, M. E. (2001). The biologically active isomers of conjugated linoleic acid. Prog. Lipid Res. 40, 283-298.
70. Parra, P., Serra, F., and Palou, A. (2010). Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS ONE 5, e13005. doi:10.1371/jour-nal.pone.0013005
71. Peyrou, M., Bourgoin, L., and Foti, M. (2010). PTEN in non-alcoholic fatty liver disease/non-alcoholic steato-hepatitis and cancer. Dig. Dis. 28, 236-246.
72. Poirier, H., Shapiro, J. S., Kim, R. J., and Lazar, M. A. (2006). Nutri-tional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes 55, 1634-1641.
73. Rayner, K. J., Esau, C. C., Hussain, F. N., McDaniel, A. L., Marshall, S. M., van Gils, J. M., Ray, T. D., Sheedy, F. J., and Goedeke, L., Liu, X., Khat-senko, O. G., Kaimal, V., Lees, C. J., Fernandez-Hernando, C., Fisher, E. A., Temel, R. E., and Moore, K. J. (2011). Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478, 404-407.
74. Raza, S. S. (2010). Diet-induced docosahexaenoic acid non-raft domains and lymphocyte function. Prostaglandins Leukot. Essent. Fatty Acids 82, 159-164.
75. Recchiuti, A., Krishnamoorthy, S., Fred-man, G., Chiang, N., and Serhan, C. N. (2011). MicroRNAs in resolu-tion of acute inflammation: identifi-cation of novel resolvin D1-miRNA circuits. FASEB J. 25, 544-560.
76. Richard, D., Bausero, P., Schneider, C., and Visioli, F. (2009a). Polyunsat-urated fatty acids and cardiovascu-lar disease. Cell.Mol.LifeSci.66, 3277-3288.
77. Richard, D., Wolf, C., Barbe, U., Kefi, K., Bausero, P., and Visioli, F. (2009b). Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling path-way. Biochem. Biophys. Res. Com-mun. 389, 516-522.
78. Richard, D., Kefi, K., Barbe, U., Bausero, P., and Visioli, F. (2008). Polyunsaturated fatty acids as antioxidants. Pharmacol. Res. 57, 451-455.
79. Riserus, U., Arner, P., Brismar, K., and Vessby, B. (2002). Treat-ment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the meta-bolic syndrome. Diabetes Care 25, 1516-1521.
80. Salehipour, M., Javadi, E., Reza, J. Z., Doosti, M., Rezaei, S., Pakne-jad, M., Nejadi, N., and Heidari, M. (2010). Polyunsaturated fatty acids and modulation of cholesterol homeostasis in THP-1 macrophage-derived foam cells. IntJMolSci11, 4660-4672.
81. Saltiel, A. R. (2010). Fishing out a sensor for anti-inflammatory oils. Cell 142, 672-674.
82. Sampath, H., and Ntambi, J. M. (2005). Polyunsaturated fatty acid regula-tion of genes of lipid metabolism. Annu.Rev.Nutr.25, 317-340.
83. Schwenk, R. W., Holloway, G. P., Luiken, J. J., Bonen, A.,and Glatz, J. F. (2010). Fatty acid transport across the cell membrane: regulation by fatty acid transporters. Prostaglandins Leukot. Essent. Fatty Acids 82, 149-154.
84. Serhan, C. N. (2009). Systems approach to inflammation resolution: identi-fication of novel anti-inflammatory and pro-resolving mediators. J. Thromb. Haemost. 7(Suppl. 1), 44-48.
85. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., and Flier, J. S. (2006). TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025.
86. Skarn, M., Namlos, H. M., Noord-huis, P., Wang, M. Y., Meza-Zepeda, L. A., and Myklebost, O. (2011). Adipocyte differenti-ation of human bone marrow-derived stromal cells is modulated by microRNA-155, microRNA-221, and microRNA-222. Stem Cells Dev. doi: 10.1089/scd.2010.0503. [Epub ahead of print].
87. Smith, W. L. (2005). Cyclooxygenases, peroxide tone and the allure of fish oil. Curr. Opin. Cell Biol. 17, 174-182.
88. Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., and Serhan, C. N. (2009). Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291.
89. Stachowska, E., Baskiewicz, M., Marchlewicz, M., Czuprynska, K., Kaczmarczyk, M., Wiszniewska, B., Machalinski, B., and Chlubek, D. (2010). Conjugated linoleic acids regulate triacylglycerol and cholesterol concentrations in macrophages/foam cells by the modulation of CD36 expression. Acta Biochim. Pol. 57, 379-384.
90. Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., and Stoffel, M. (2011). MicroRNAs 103 and 107 regu-late insulin sensitivity. Nature 474, 649-653.
91. Vasudevan, S., Tong, Y., and Steitz, J. A. (2007). Switching from repres-sion to activation: microRNAs can up-regulate translation. Science 318, 1931-1934.
92. Vaughan, A. M., and Oram, J. F. (2006). ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J. Lipid Res. 47, 2433-2443.
93. Vinciguerra, M., and Foti, M. (2008). PTEN at the crossroad of metabolic diseases and cancer in the liver. Ann. Hepatol. 7, 192-199.
94. Vinciguerra, M., Sgroi, A., Veyrat-Durebex, C., Rubbia-Brandt, L., Buhler, L. H., and Foti, M. (2009). Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatol-ogy 49, 1176-1184.
95. Visioli, F., and Hagen, T. M. (2011). Antioxidants to enhance fertil-ity: role of eNOS and poten-tial benefits. Pharmacol. Res. 64, 431-437.
96. Wang, H., Chen, X., and Fisher, E. A. (1993). N-3 fatty acids stimulate intracellular degradation of apopro-tein B in rat hepatocytes. J. Clin. Invest. 91, 1380-1389.
97. Wang, N., Lan, D., Chen, W., Mat-suura, F., and Tall, A. R. (2004a). ATP-binding cassette transporters G1 and G4 mediate cellular choles-terol efflux to high-density lipopro-teins. Proc. Natl. Acad. Sci. U.S.A. 101, 9774-9779.
98. Wang, Y., Kurdi-Haidar, B., and Oram, J. F. (2004b). LXR-mediated activation of macrophage stearoyl-CoA desat-urase generates unsaturated fatty acids that destabilize ABCA1. J. Lipid Res. 45, 972-980.
99. Wang, Y., and Oram, J. F. (2002). Unsat-urated fatty acids inhibit cholesterol efflux from macrophages by increas-ing degradation of ATP-binding cas-sette transporter A1. J. Biol. Chem. 277, 5692-5697.
100. Wang, Y., and Oram, J. F. (2005). Unsat-urated fatty acids phosphorylate and destabilize ABCA1 through a phos-pholipase D2 pathway. J. Biol. Chem. 280, 35896-35903.
101. Wang, Y., and Oram, J. F. (2007). Unsat-urated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J. Lipid Res. 48, 1062-1068.
102. Wenzel, J. J., Piehler, A., and Kaminski, W. E. (2007). ABC A-subclass proteins: gatekeepers of cellu-lar phospho-and sphingolipid transport. Front. Biosci. 12, 3177-3193.
103. Whigham, L. D., Watras, A. C., and Schoeller, D. A. (2007). Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am. J. Clin. Nutr. 85, 1203-1211.
104. Wightman, B., Ha, I., and Ruvkun, G. (1993). Posttranscriptional regula-tion of the heterochronic gene lin-14 by lin-4 mediates temporal pat-tern formation in C. elegans. Cell 75, 855-862.
105. Yang, J. S., and Lai, E. C. (2011). Alternative miRNA biogenesis path-ways and the interpretation of core miRNA pathway mutants. Mol. Cell 43, 892-903.
106. Yang, Y., Jiang, Y., Wang, Y., and An, W. (2010). Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells. Biochimie 92, 958-963.